MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients

Objective: Tyrosine kinase inhibitors (TKIs) are used for the treatment of metastatic differentiated (DTC), poorly differentiated (PDTC) and medullary (MTC) thyroid cancer. Several adverse events (AEs) have been reported in almost all patients (pts) treated with TKIs. One of the less known AE relate...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:J Endocr Soc
Główni autorzy: Valerio, Laura, Matrone, Antonio, Agate, Laura, Bottici, Valeria, Viola, David, Cappagli, Virginia, Giani, Carlotta, Molinaro, Eleonora, Elisei, Rossella
Format: Artigo
Język:Inglês
Wydane: Oxford University Press 2020
Hasła przedmiotowe:
Thyroid
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209016/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1647
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy